基于CRISPR的基因组编辑方法对人类细胞巨乳病毒感染的应用
Andra Zhang1,2, Isadora Zhang1,3, Fenyong Liu1,3
1School of Public Health, University of California, Berkeley, CA 94720, USA.
Biomedicines
|July 29, 2025
概括
新的CRISPR-Cas基因组编辑显示出消除临床和潜伏人类细胞巨乳病毒 (HCMV) 感染的前景,为这种广泛传播的病原体提供了新的治疗策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 人类细胞巨乳病毒 (HCMV) 建立了终身潜伏感染,并在免疫功能低下的人和先天性感染中引起严重并发症.
- 目前的疗法可以抑制溶性HCMV,但无法根除潜伏的病毒基因组,突出显示了严重的未满足的医疗需求.
研究的目的:
- 审查应用CRISPR-Cas基因组编辑技术研究和抑制HCMV.最近的进展.
- 讨论基于CRISPR的方法对控制HCMV感染和相关疾病的治疗潜力.
主要方法:
- 审查关于CRISPR-Cas应用对HCMV的当前文献.
- 分析CRISPR-Cas针对病毒遗传物质的机制.
主要成果:
- 克里斯普尔-卡斯系统显示出改变或破坏HCMV遗传物质的潜力.
- 这项技术提供了一种新的策略,可以对抗活跃和潜伏的HCMV感染.
结论:
- 基因组编辑CRISPR-Cas代表了一个有前途的抗病毒方法对HCMV.
- 进一步开发基于CRISPR的疗法可能会导致对HCMV感染和相关病理的有效治疗.
相关概念视频
CRISPR/Cas9 Genome Editing
252
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
252
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K


